Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Blood Donation for the Development of the Microvisk PT/INR

NCT06648837 is registered in ClinicalTrials.gov with Microvisk Technologies Ltd as lead sponsor.

NCT NCT06648837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Blood Donation for the Development of the Microvisk PT/INR
Lead sponsor
Microvisk Technologies Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 13, 2025
Completion date
November 1, 2029
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), deep vein thrombosis, pulmonary embolism (diagnosis)